Zhenyi Su
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 10%
- Epidemiology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Signaling Pathways in Disease (10 papers)NF-κB Signaling Pathways (9 papers)Cell death mechanisms and regulation (6 papers)
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Zhenyi Su
29 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 1.4k
- Cancer Research 714
- Oncology 408
- Epidemiology 380
- Pulmonary and Respiratory Medicine 327
Countries citing papers authored by Zhenyi Su
This map shows the geographic impact of Zhenyi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyi Su more than expected).
Fields of papers citing papers by Zhenyi Su
This network shows the impact of papers produced by Zhenyi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyi Su. The network helps show where Zhenyi Su may publish in the future.
Co-authorship network of co-authors of Zhenyi Su
This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyi Su. A scholar is included among the top collaborators of Zhenyi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyi Su. Zhenyi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | Understanding the complexity of p53 in a new era of tumor suppressionbreakdown → | 187 |
| 6 | 11 | |
| 7 | 65 | |
| 8 | 36 | |
| 9 | 22 | |
| 10 | 17 | |
| 11 | 82 | |
| 12 | 275 | |
| 13 | Apoptosis, autophagy, necroptosis, and cancer metastasisbreakdown → | 794 |
| 14 | 22 | |
| 15 | 24 | |
| 16 | 13 | |
| 17 | 8 | |
| 18 | 6 | |
| 19 | 8 | |
| 20 | 13 |
About Zhenyi Su
Zhenyi Su is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 31 papers that have together received 2.2k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (10 papers), NF-κB Signaling Pathways (9 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Cancer Research (714 citations), Molecular Biology (1.4k citations) and Oncology (408 citations). Zhenyi Su has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Zuozhang Yang, Qiang Yu, Yongqing Xu, Yongbin Chen, Yongbin Chen, Judy Park DeWitt, Wei Gu, Lin Xie, Yanqing Liu and Omid Tavana. Their work appears in journals such as Genes & Development, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.